3 Biggest Risks for Bristol-Myers Squibb in 2017

3 Biggest Risks for Bristol-Myers Squibb in 2017


Earnings more than doubled. Can the big drugmaker perform as well in 2017? Here are three of the biggest risks that Bristol-Myers Squibb faces in the new year.



from Biotech News